Sumnman-A tissue-isolated preparation of the P22 rat carcinosarcoma was used to investigate the tumour vascular response to angiotensin II (ATII). In particular. the relative importance of systemic and local tumour factors was assessed by comparing tumour vascular resistance during systemic administration of ATII and during administration directly into the tumour-supplying artery. The effect of hypervolaemia on tumour vascular resistance was determined as well as the effect of ATII on oxygen metabolism. Tumour vascular resistance was increased by ATII in a dose-dependent manner. The response was biphasic with an initial peak in resistance followed by a lower plateau phase. Systemic administration of ATII was more effective in increasing tumour vascular resistance than direct administration. This suggests that systemic administration is not causing any reopening of previously collapsed tumour blood vessels. Further evidence for this is that hypervolaemia caused no reduction in tumour vascular resistance and that there was no difference in oxygen extraction by tumours between groups treated with systemically and directly administered ATII. A heterogeneous distribution of ATII receptors in the P22 tumour is a more likely explanation for the known heterogeneity of blood flow response to ATII.Kewords: P22 tumour; angiotensin II: vascular resistance; blood flow; oxygen metabolism Intravenous infusion of angiotensin II (ATII) has been found to increase tumour blood flow relative to most normal tissues, and this has led to the concept of 'hypertension chemotherapy'. in which ATII is used to improve the relative delivery of chemotherapeutic agents to tumours (Susuki et al., 1981;Takematsu et al.. 1985;Noguchi et al., 1988;Kobayashi et al.. 1990Kobayashi et al.. . 1991Anderson et al., 1991;Kerr et al., 1992; Mutoh et al., 1992). However, in absolute terms, ATII has been found to increase blood flow in some tumours (Tokuda et al.. 1990; Honr et al., 1991;Tanda et al., 1991) while decreasing it in others (Jirtle et al., 1978;Tozer and Shaffi, 1993). A decrease in absolute tumour blood flow could compromise delivery of drug to tumour microregions. Whether tumour blood flow increases or decreases is dependent upon the balance between drug-induced hypertension ansing from systemic vasoconstriction and local vasoconstriction induced within the tumour itself (since blood flow = perfusion pressure . vascular resistance). Presumably, this balance varies with tumour type. although the underlying factors which determine response remain unclear. It is important to identify these factors in order to predict the response of a particular tumour to ATII.We have previously found that ATII causes a significant increase in the vascular resistance of early generation, subcutaneous transplants of the P22 rat carcinosarcoma Tozer et al., 1994a). We also found that the degree of vasoconstriction induced by ATII was dependent on pretreatment blood flow. That is, in whole tumours, vasoconstriction was greatest where blood flow to control tumours...